Cargando…
An investigation on [5 fluorouracil and epigallocatechin-3-gallate] complex activity on HT-29 cell death and its stability in gastrointestinal fluid
Recently an enhancement of the sensitivity of colorectal cancer (CRC) cells by 5-fluorouracil (5FU) due to the concurrent treatment with epigallocatechin-3-gallate (EGCG) has been found. In the present paper, to investigate on this aspect, adenocarcinoma cells HT29 were treated with 5FU, EGCG and an...
Autores principales: | Moracci, Laura, Sensi, Francesca, Biccari, Andrea, Crotti, Sara, Gaio, Elisa, Benetti, Federico, Traldi, Pietro, Pucciarelli, Salvatore, Agostini, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893781/ https://www.ncbi.nlm.nih.gov/pubmed/35251495 http://dx.doi.org/10.18632/oncotarget.28207 |
Ejemplares similares
-
The Study of the Extracellular Matrix in Chronic Inflammation: A Way to Prevent Cancer Initiation?
por: Marangio, Asia, et al.
Publicado: (2022) -
Skin Protective Effect of Epigallocatechin Gallate
por: Kim, Eunji, et al.
Publicado: (2018) -
Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer
por: Toden, Shusuke, et al.
Publicado: (2016) -
Role of Epigallocatechin Gallate in Glucose, Lipid, and Protein Metabolism and L-Theanine in the Metabolism-Regulatory Effects of Epigallocatechin Gallate
por: Lin, Ling, et al.
Publicado: (2021) -
Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy
por: Granja, Andreia, et al.
Publicado: (2016)